116 related articles for article (PubMed ID: 7659387)
1. 111In-oxine-labelled granulocyte dosimetry in normal subjects.
Forstrom LA; Dunn WL; Rowe FA; Camilleri M
Nucl Med Commun; 1995 May; 16(5):349-56. PubMed ID: 7659387
[TBL] [Abstract][Full Text] [Related]
2. Indium-111-labeled white blood cells: dosimetry in children.
Gainey MA; Siegel JA; Smergel EM; Jara BJ
J Nucl Med; 1988 May; 29(5):689-94. PubMed ID: 3131501
[TBL] [Abstract][Full Text] [Related]
3. Indium-111-labelled liposomes: dosimetry and tumour detection in patients with cancer.
Kubo A; Nakamura K; Sammiya T; Katayama M; Hashimoto T; Hashimoto S; Kobayashi H; Teramoto T
Eur J Nucl Med; 1993 Feb; 20(2):107-13. PubMed ID: 8440266
[TBL] [Abstract][Full Text] [Related]
4. In vivo traffic of indium-111-oxine labeled human lymphocytes collected by automated apheresis.
Read EJ; Keenan AM; Carter CS; Yolles PS; Davey RJ
J Nucl Med; 1990 Jun; 31(6):999-1006. PubMed ID: 2112185
[TBL] [Abstract][Full Text] [Related]
5. Radiation dose from human platelets labelled with indium 111.
van Reenen OR; Lötter MG; Minnaar PC; Heyns Adu P; Badenhorst PN; Pieters H
Br J Radiol; 1980 Aug; 53(632):790-5. PubMed ID: 6777011
[TBL] [Abstract][Full Text] [Related]
6. PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab.
Makris NE; Boellaard R; van Lingen A; Lammertsma AA; van Dongen GA; Verheul HM; Menke CW; Huisman MC
J Nucl Med; 2015 Feb; 56(2):249-54. PubMed ID: 25613538
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans.
Kemerink GJ; Boersma HH; Thimister PW; Hofstra L; Liem IH; Pakbiers MT; Janssen D; Reutelingsperger CP; Heidendal GA
Eur J Nucl Med; 2001 Sep; 28(9):1373-8. PubMed ID: 11585297
[TBL] [Abstract][Full Text] [Related]
8. Comparison of In-111 granulocytes and Tc-99m albumin colloid for bone marrow scintigraphy by the use of quantitative SPECT imaging.
Axelsson B; Kalin B; Von Krusenstierna S; Jacobsson H
Clin Nucl Med; 1990 Jul; 15(7):473-9. PubMed ID: 2116948
[TBL] [Abstract][Full Text] [Related]
9. An improved method for the quantification of the in vivo kinetics of a representative population of 111In-labelled human platelets.
Wessels P; Heyns AD; Pieters H; Lötter MG; Badenhorst PN
Eur J Nucl Med; 1985; 10(11-12):522-7. PubMed ID: 3928383
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte accumulation in the transplanted liver does not correlate with clinical and histologic evidence of dysfunction.
Ziser A; Forstrom LA; Plevak DJ; Sanchez-Urdazpal L; Gores GJ; Wiesner RH; Batts KP; Krom RA
Invest Radiol; 1996 Mar; 31(3):132-7. PubMed ID: 8675420
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 99Tcm-HMPAO and 111In-oxine labelled granulocytes in man: first clinical results.
Becker W; Schomann E; Fischbach W; Börner W; Gruner KR
Nucl Med Commun; 1988 Jun; 9(6):435-47. PubMed ID: 3137513
[TBL] [Abstract][Full Text] [Related]
12. Scintigraphic biodistribution and plasma kinetics of indium 111-labeled transferrin in dogs.
Berry CR; Fisher P; Koblik PD; Guilford WG; Hornof WH
Am J Vet Res; 1997 Nov; 58(11):1188-92. PubMed ID: 9361875
[TBL] [Abstract][Full Text] [Related]
13. Double-tracer dosimetry of organs in assessment of bone marrow involvement by two monoclonal antibodies.
Korppi-Tommola ET; Kairemo KJ; Jekunen AP; Niskanen EO; Savolainen SE
Acta Oncol; 1996; 35(3):357-65. PubMed ID: 8679267
[TBL] [Abstract][Full Text] [Related]
14. Quantification of pulmonary uptake of indium-111 labelled granulocytes in inflammatory bowel disease.
Ussov WY; Peters AM; Hodgson HJ; Hughes JM
Eur J Nucl Med; 1994 Jan; 21(1):6-11. PubMed ID: 8088288
[TBL] [Abstract][Full Text] [Related]
15. Improving bone marrow scintigraphy. A clinical and experimental study.
Kalin B
Acta Radiol Suppl; 1993; 385():1-24. PubMed ID: 8517188
[TBL] [Abstract][Full Text] [Related]
16. Patient-specific dosimetry of pretargeted radioimmunotherapy using CC49 fusion protein in patients with gastrointestinal malignancies.
Shen S; Forero A; LoBuglio AF; Breitz H; Khazaeli MB; Fisher DR; Wang W; Meredith RF
J Nucl Med; 2005 Apr; 46(4):642-51. PubMed ID: 15809487
[TBL] [Abstract][Full Text] [Related]
17. Kinetics, distribution, and sites of destruction of indium-111 oxine labelled red cells in haemolytic anaemia.
Heyns AD; Lötter MG; Kotzè HF; Wessels P; Pieters H; Badenhorst PN
J Clin Pathol; 1985 Feb; 38(2):128-32. PubMed ID: 3918078
[TBL] [Abstract][Full Text] [Related]
18. The kinetics of 111indium distribution following injection of 111indium labelled autologous granulocytes in man.
Saverymuttu SH; Peters AM; Keshavarzian A; Reavy HJ; Lavender JP
Br J Haematol; 1985 Dec; 61(4):675-85. PubMed ID: 4084457
[TBL] [Abstract][Full Text] [Related]
19. Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
Virgolini I; Szilvasi I; Kurtaran A; Angelberger P; Raderer M; Havlik E; Vorbeck F; Bischof C; Leimer M; Dorner G; Kletter K; Niederle B; Scheithauer W; Smith-Jones P
J Nucl Med; 1998 Nov; 39(11):1928-36. PubMed ID: 9829585
[TBL] [Abstract][Full Text] [Related]
20. Human platelets labeled with In-111 8-hydroxyquinoline: kinetics, distribution, and estimates of radiation dose.
Scheffel U; Tsan MF; Mitchell TG; Camargo EE; Braine H; Ezekowitz MD; Nickoloff EL; Hill-Zobel R; Murphy E; McIntyre PA
J Nucl Med; 1982 Feb; 23(2):149-56. PubMed ID: 6799622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
